Colorectal Cancer

Volker Heinemann says early tumor shrinkage may be a better predictor than progression-free survival in colorectal cancer.

CURE spoke with Axel Grothey about advances in the treatment of colorectal cancer.

A wide-range of colon cancer screening options will be available and insured for patients, thanks to recent USPSTF recommendations.

The combination of Opdivo and Yervoy showed promise for certain patients with colorectal cancer in a phase 2 study.

While inherited factors do play a role in many people getting colorectal cancer, researchers are still unsure how to identify these mutations.

Patients' confidence that they can manage problems related to their colorectal cancer can have a great impact on their recovery, according to a recent study.

The location of colon cancer may have a say in survival, according to a recent analysis.

Since chemotherapy can offer only a limited amount of help in fighting gastroesophageal cancers, a growing emphasis on prevention — as well as on the development of immunotherapies — will be extremely important.

In the midst of the approval of new treatments for colorectal cancer, Alan P. Venook wants to remind health care professionals not to forget the more traditional and established therapies.

In the oncology world, gastrointestinal cancers may be the next in line to realize the promise of immunotherapy.

David Dubin, founder, AliveAndKickn, provides advice for Lynch syndrome previvors.

While many advocacy groups concentrate their efforts on raising awareness or finding a cure for cancer, PCF has always had its focus squarely on prevention and patient education.

"We've shown for the first time that an alternative to standard chemoradiation is well tolerated with lower acute toxicity," said co-author Lucjan Wyrwicz.

The trials and tribulations of cancer often morphed with the celebration of simple milestones that allowed my journey to cross the paths of others who became positive influences in my life.

Exactly one month after an oncologist told her that there was an 80 percent chance she was free of colon cancer, Taylor Arnold sat in front of a panel of patients, survivors and doctors, wondering why she was there.

Every cancer conference is a chance for me to learn.

The designation, which will expedite the development and review of Keytruda in this space, was based on findings from an ongoing phase 2 study.